Article

MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration…

medRxiv · 2025 · Kline, E. M.; Jernigan, J. E.; Scharer, C. D.; Maurer, J.; Hicks, S. L.; Herrick, M. K.; Wallings, R. L.; Kelly, S. D.; Chang, J.; Menees, K. B.; McFarland, N. R.; Boss, J. M.; Tansey, M. G.; Joers, V.

Key facts

Title MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation
First author Kline, E. M.; Jernigan, J. E.; Scharer, C. D.; Maurer, J.; Hicks, S. L.; Herrick, M. K.; Wallings, R. L.; Kelly, S. D.; Chang, J.; Menees, K. B.; McFarland, N. R.; Boss, J. M.; Tansey, M. G.; Joers, V.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2024.08.31.610581
Devices mentioned 018956, BK110039, K010696, K103302, K110701, K123955, K141410, K152556, K192920
Product codes mentioned CEK, GIA, JJH, KIP, KIT, MVU, NJT, OOI, OYJ, PFT, JIS, NDS and 1 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature